Background: The pigmented and unwanted hair in females is a common issue. There are various treatment modalities available for facial hair removal, (temporary and permanent.) The client choice is invariably to remove facial hair permanently. The photoepilation laser and IPL treatment to remove unwanted facial hair is an acceptable universal method. Objective: To determine the role of photo epilation in the treatment of female facial hirsutism patients. Methods: In this prospective study, carried out from May 2014 to May 2016 in Aziz Fatimah Hospital & Faisal Hospital, Faisalabad, Pakistan.we have treated 140 female clients with the age of 19 Yrs to 55yrs (mean age 36.5 Yrs) having facial hirsutism with Ferriman-Galway score of 8 or more. All patients were treated with photoepilation hair removal system. Thirty four(24.29%) patients excluded from the study due to non-compliance. Normally 4 sessions of photoepilation treatment spaced 30 days deemed sufficient for permanent facial hair removal. With the first session we consider to have 50 % reduction of facial hair and further 10- 20% with every subsequent four to five sessions, spaced 30 days each session accumulating 100% removal of unwanted facial hair in 4 – 5 months. In patients, who did not achieved the desired results after 2nd sessions, we further evaluated for the medical diagnosis for resistant facial hair regrowth and 14 (10%) patients with the hormonal imbalance diagnosed were treated with medical therapy by a specialist endocrinologist. Results: Overall results achieved are highly satisfactory (approximately 80%). All patients with hormonal imbalance had joint treatment from specialist Endocrinologist and Aesthetic/Cosmetic Surgeon. The results achieved after combined treatment with photoepilation and medical therapy were total elimination of resistant or regrowth of female facial hirsutism. Conclusions: Where response is inappropriate after 2-3 photoepilation sessions for female facial hair removal then client should be evaluated further by an experienced endocrinologist. After making correct diagnosis of female facial hirsutism and treating medically, the results achieved to remove female facial hair with photoepilation remained satisfactory
1. Hatasaka HH, Wentz AC .Hirsutism: f a c t s a n d f o l k l o r e . P a r t I I : management options. Female Patient. 1991;16:73–81.
2. DierickxCC .Hair removal by lasers and intense pulsed light sources. S e m i n C u t a n M e d S u r g . 2000;19:267–75.
3. Dierickx CC, Alora MB, Dover JS .A clinical overview of hair removal using lasers and light sources. DermatolClin. 1999;17:357–66.
4. Eflornithine cream for facial hair reduction. Med Lett Drugs Ther. 2000;42:96.
5. Knochenhauer ES, Key TJ, Kahsar- Miller M, Waggoner W, Boots LR, AzzizR . Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J C l i n E n d o c r i n o l M e t a b . 1998;83:3078–82.
6. R e d m o n d G P, B e r g f e l d W F . Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med. 1990;57:423–7.
7. Givens JR, Kurtz BR. Hirsutism, virilization, and androgen excess. In: Hurst JW, Ambrose SS, et al., eds. Medicine for the practicing physician. 3 d e d . B o s t o n : B u t t e r w o r t h – Heinemann, 1992:568–71.
8. Hickman JG, Huber F, PalmisanoM . Human dermal safety studies with e fl o r n i t h i n e H C l 1 3 . 9 % c r e a m (Vaniqa), a novel treatment for excessive facial hair. Curr Med Res Opin. 2001;16:235–44.
9. Venturoli S, Fabbri R, Dal Prato L, Mantovani B, Capelli M, Magrini O, et al. Ketoconazole therapy for women with acne and/or hirsutism. J C l i n E n d o c r i n o l M e t a b .
1990;71:335–9.
10. T h o r n e y c r o f t I H . U p d a t e o n androgenicity. Am J Obstet Gynecol. 1999;1802Pt 2:288–94.
11. Lemay A, Dewailly SD, Grenier R, Huard J . Attenuation of mild h y p e r a n d r o g e n i c a c t i v i t y i n postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,1-norgestrel. J ClinEndocrinolMetab. 1990;71:8–14.
12. Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R .Changes in androgens during treatment with four l o w – d o s e c o n t r a c e p t i v e s . Contraception. 1996;53:171–6.
13. Pazos F, Escobar-Morreale HF, Balsa J, Sancho JM, Varela C . Prospective randomized study comparing the long-acting gonadotropin-releasing h o r m o n e a g o n i s t t r i p t o r e l i n , flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of h i r s u t i s m . F e r t i l S t e r i l .
1999;71:122–8.
14. Moghetti P, Tosi F, Tosti A, Negri C, M i s c i a l i C , P e r r o n e F, e t a l . Comparison of spironolactone, flutamide, and nasteride efcacy in t h e t r e a t m e n t o f h i r s u t i s m : a randomized, double blind, placeboc o n t r o l l e d t r i a l . J C l i n E n d o c r i n o l M e t a b . 2000;85:89–94.
15. Wong IL, Morris RS, Chang L, Spahn MA, Stanczyk FZ, Lobo RA .A p r o s p e c t i v e r a n d o m i z e d t r i a l c o m p a r i n g n a s t e r i d e t o spironolactone in the treatment of h i r s u t e w o m e n . J C l i n E n d o c r i n o l M e t a b . 1995;80:233–8.
All published material becomes the sole property of the Pakistan Journal of Plastic Surgery, copyrighted by the Pakistan Association of Plastic Surgeons (PAPS). By submitting an article or brief communication, all authors agree to these conditions.
During the submission process, all authors have required to complete a copyright transfer agreement, “Author Consent form” By completing the copyright transfer agreement, you are transferring copyright of figures, tables, videos, and the content of the manuscript to the Pakistan Association of Plastic Surgeons (PAPS).
If you do not wish to or cannot transfer copyright of some or all of your content, please contact the editorial office at pjpspakistan@gmail.com